Press release
Narcotic (Opioid) Drugs Market 2021-2027: Industry Growth, Competitive Analysis & Future Prospects | Pfizer, Teva, Purdue Pharma
LOS ANGELES, United States: The report is an all-inclusive research study of the global Narcotic (Opioid) Drugs market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Narcotic (Opioid) Drugs market with the help of research methodologies such as PESTLE and Porter’s Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Narcotic (Opioid) Drugs report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/sample-form/form/3209153/global-narcotic-opioid-drugs-market
Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Narcotic (Opioid) Drugs market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Narcotic (Opioid) Drugs market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.
Key Players Mentioned in the Global Narcotic (Opioid) Drugs Market Research Report: Pfizer, Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Merck, Mylan, Hikma Pharmaceuticals, Sun Pharma, Endo Pharmaceuticals, Allergan
Global Narcotic (Opioid) Drugs Market Segmentation by Product: Codeine, Fentanyl, Hydrocodone, Hydromorphone, Meperidine, Methadone, Others
Global Narcotic (Opioid) Drugs Market Segmentation by Application: Pain Relief Application, Anesthesia Application
The Narcotic (Opioid) Drugs Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Narcotic (Opioid) Drugs market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Narcotic (Opioid) Drugs market and its potential to grow in the years to come.
Key questions answered in the report:
What is the growth potential of the Narcotic (Opioid) Drugs market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in Narcotic (Opioid) Drugs industry in the years to come?
What are the key challenges that the global Narcotic (Opioid) Drugs market may face in future?
Which are the leading companies in the global Narcotic (Opioid) Drugs market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Narcotic (Opioid) Drugs market?
Request for customization in Report:
https://www.qyresearch.com/customize-request/form/3209153/global-narcotic-opioid-drugs-market
TOC
1 Market Overview of Narcotic (Opioid) Drugs
1.1 Narcotic (Opioid) Drugs Market Overview
1.1.1 Narcotic (Opioid) Drugs Product Scope
1.1.2 Narcotic (Opioid) Drugs Market Status and Outlook
1.2 Global Narcotic (Opioid) Drugs Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Narcotic (Opioid) Drugs Market Size by Region (2016-2027)
1.4 Global Narcotic (Opioid) Drugs Historic Market Size by Region (2016-2021)
1.5 Global Narcotic (Opioid) Drugs Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Narcotic (Opioid) Drugs Market Size (2016-2027)
1.6.1 North America Narcotic (Opioid) Drugs Market Size (2016-2027)
1.6.2 Europe Narcotic (Opioid) Drugs Market Size (2016-2027)
1.6.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2016-2027)
1.6.4 Latin America Narcotic (Opioid) Drugs Market Size (2016-2027)
1.6.5 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2016-2027) 2 Narcotic (Opioid) Drugs Market Overview by Type
2.1 Global Narcotic (Opioid) Drugs Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2016-2021)
2.3 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2022-2027)
2.4 Codeine
2.5 Fentanyl
2.6 Hydrocodone
2.7 Hydromorphone
2.8 Meperidine
2.9 Methadone
2.10 Others 3 Narcotic (Opioid) Drugs Market Overview by Application
3.1 Global Narcotic (Opioid) Drugs Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2016-2021)
3.3 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2022-2027)
3.4 Pain Relief Application
3.5 Anesthesia Application 4 Narcotic (Opioid) Drugs Competition Analysis by Players
4.1 Global Narcotic (Opioid) Drugs Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2020)
4.3 Date of Key Players Enter into Narcotic (Opioid) Drugs Market
4.4 Global Top Players Narcotic (Opioid) Drugs Headquarters and Area Served
4.5 Key Players Narcotic (Opioid) Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Narcotic (Opioid) Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Narcotic (Opioid) Drugs Products, Services and Solutions
5.1.4 Pfizer Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.1.5 Pfizer Recent Developments
5.2 Teva
5.2.1 Teva Profile
5.2.2 Teva Main Business
5.2.3 Teva Narcotic (Opioid) Drugs Products, Services and Solutions
5.2.4 Teva Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.2.5 Teva Recent Developments
5.3 Purdue Pharma
5.5.1 Purdue Pharma Profile
5.3.2 Purdue Pharma Main Business
5.3.3 Purdue Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
5.3.4 Purdue Pharma Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.3.5 Mallinckrodt Recent Developments
5.4 Mallinckrodt
5.4.1 Mallinckrodt Profile
5.4.2 Mallinckrodt Main Business
5.4.3 Mallinckrodt Narcotic (Opioid) Drugs Products, Services and Solutions
5.4.4 Mallinckrodt Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.4.5 Mallinckrodt Recent Developments
5.5 Amneal Pharma
5.5.1 Amneal Pharma Profile
5.5.2 Amneal Pharma Main Business
5.5.3 Amneal Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
5.5.4 Amneal Pharma Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.5.5 Amneal Pharma Recent Developments
5.6 Collegium
5.6.1 Collegium Profile
5.6.2 Collegium Main Business
5.6.3 Collegium Narcotic (Opioid) Drugs Products, Services and Solutions
5.6.4 Collegium Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.6.5 Collegium Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Products, Services and Solutions
5.7.4 Johnson & Johnson Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.7.5 Johnson & Johnson Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Narcotic (Opioid) Drugs Products, Services and Solutions
5.8.4 Merck Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.8.5 Merck Recent Developments
5.9 Mylan
5.9.1 Mylan Profile
5.9.2 Mylan Main Business
5.9.3 Mylan Narcotic (Opioid) Drugs Products, Services and Solutions
5.9.4 Mylan Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.9.5 Mylan Recent Developments
5.10 Hikma Pharmaceuticals
5.10.1 Hikma Pharmaceuticals Profile
5.10.2 Hikma Pharmaceuticals Main Business
5.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Products, Services and Solutions
5.10.4 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.10.5 Hikma Pharmaceuticals Recent Developments
5.11 Sun Pharma
5.11.1 Sun Pharma Profile
5.11.2 Sun Pharma Main Business
5.11.3 Sun Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
5.11.4 Sun Pharma Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.11.5 Sun Pharma Recent Developments
5.12 Endo Pharmaceuticals
5.12.1 Endo Pharmaceuticals Profile
5.12.2 Endo Pharmaceuticals Main Business
5.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Products, Services and Solutions
5.12.4 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.12.5 Endo Pharmaceuticals Recent Developments
5.13 Allergan
5.13.1 Allergan Profile
5.13.2 Allergan Main Business
5.13.3 Allergan Narcotic (Opioid) Drugs Products, Services and Solutions
5.13.4 Allergan Narcotic (Opioid) Drugs Revenue (US$ Million) & (2016-2021)
5.13.5 Allergan Recent Developments 6 North America
6.1 North America Narcotic (Opioid) Drugs Market Size by Country (2016-2027)
6.2 United States
6.3 Canada 7 Europe
7.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe 8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific 9 Latin America
9.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America 10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa 11 Narcotic (Opioid) Drugs Market Dynamics
11.1 Narcotic (Opioid) Drugs Industry Trends
11.2 Narcotic (Opioid) Drugs Market Drivers
11.3 Narcotic (Opioid) Drugs Market Challenges
11.4 Narcotic (Opioid) Drugs Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com
About Us
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Narcotic (Opioid) Drugs Market 2021-2027: Industry Growth, Competitive Analysis & Future Prospects | Pfizer, Teva, Purdue Pharma here
News-ID: 2307932 • Views: …
More Releases from QY Research, Inc
Micro Reaction Calorimeter Market to Reach US$ 244 Million by 2031, Supported by …
Market Summary -
The global market for Micro Reaction Calorimeter was estimated to be worth US$ 175 million in 2024 and is forecast to a readjusted size of US$ 244 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
According to QY Research, a new publication titled "Micro Reaction Calorimeter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides an in-depth, data-driven analysis of…
Helium Turboexpander Market to Reach US$ 169 Million by 2031, Driven by Cryogeni …
Market Summary -
The global market for Helium Turboexpander was estimated to be worth US$ 118 million in 2024 and is forecast to a readjusted size of US$ 169 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
According to QY Research, a new publication titled "Helium Turboexpander - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides an in-depth, data-driven analysis of the global…
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder…
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid
The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow…
More Releases for Narcotic
Role Of Rising Chronic Disease Incidence In Driving Growth Of The Narcotic Drug …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Narcotic Drugs Market Size By 2025?
In recent times, there has been stable growth in the market size of narcotic drugs. An elevation from $14.26 billion in 2024 to $14.71 billion in 2025, amounting to a compound annual growth rate (CAGR) of 3.1%, is predicted.…
Narcotic Overdose Market New Product Development & Latest Trends
Narcotic Overdose Market Outlook 2024-2034: Expanding Treatment Solutions Amid Rising Global Crisis
Introduction
Narcotic overdose, primarily driven by opioids such as fentanyl,oxycodone, and morphine, has emerged as one of the most pressing public health crises of the 21st century. With overdose-related deaths surging globally, governments, healthcare providers, and pharmaceutical innovators are working to expand access to life-saving antidotes, preventive programs, and rehabilitation solutions.
The rising burden of opioid misuse has created an urgent…
Navigating Regulation and Demand: Trends in the Narcotic Drugs Market
The Narcotic Drugs Market sector is undergoing significant transformation, with substantial growth and technological advancements expected by 2031. According to a new in-depth market research report, the sector is poised for expansion, driven by various factors such as market size, share, and emerging trends.
This comprehensive report provides key insights into the Narcotic Drugs market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering a clear…
Narcotic Drugs Market - Industry Trends and Forecast to 2029
Data Bridge Market Research analyses a growth rate in the global narcotic drugs market in the forecast period 2022-2029. The expected CAGR of global narcotic drugs market is tend to be around 4.0% in the mentioned forecast period. The market was valued at USD 13 billion in 2021, and it would grow upto USD 17.79 billion by 2029. In addition to the market insights such as market value, growth rate,…
Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the…
Prescription Narcotic Cough Preparations and Expectorants Market
Narcotic preparations are medicines that primarily induce sleep. The basic three narcotics are morphine, codeine, and thebaine. Mucokinetics are drugs that clear mucus from the lungs, airways, trachea, and bronchi. Mucokinetics can be divided into expectorants, mucolytic agents, and surfactants. Expectorant signals the body to amplify the quantity or hydration of secretions, thereby resulting into clearer secretions. As a byproduct, expectorant lubricates the respiratory tract. Guaifenesin, an expectorant is commonly…
